INR 800.95
(-4.21%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 1.82 Billion INR | -40.52% |
2022 | 3.07 Billion INR | -35.5% |
2021 | 4.76 Billion INR | 776.97% |
2020 | 543.59 Million INR | 32846.39% |
2019 | -1.66 Million INR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 590 Million INR | 21.05% |
2024 Q1 | 487.4 Million INR | 66.63% |
2023 Q2 | 574.9 Million INR | -0.17% |
2023 FY | 1.82 Billion INR | -40.52% |
2023 Q4 | 292.5 Million INR | -24.14% |
2023 Q3 | 385.6 Million INR | -32.93% |
2023 Q1 | 575.9 Million INR | 10.1% |
2022 Q2 | 842.8 Million INR | 6.17% |
2022 Q1 | 793.8 Million INR | 15.73% |
2022 FY | 3.07 Billion INR | -35.5% |
2022 Q4 | 523.07 Million INR | -42.85% |
2022 Q3 | 915.3 Million INR | 8.6% |
2021 FY | 4.76 Billion INR | 776.97% |
2021 Q4 | 685.91 Million INR | -46.86% |
2021 Q3 | 1.29 Billion INR | 16.5% |
2021 Q2 | 1.1 Billion INR | -34.16% |
2021 Q1 | 1.68 Billion INR | 209.5% |
2020 Q4 | 543.64 Million INR | 200.0% |
2020 Q3 | -543.65 Million INR | -132.31% |
2020 Q2 | 1.68 Billion INR | 0.0% |
2020 FY | 543.59 Million INR | 32846.39% |
2019 FY | -1.66 Million INR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Biocon Limited | 10.22 Billion INR | 82.114% |
Blue Jet Healthcare Limited | 1.63 Billion INR | -11.687% |
Concord Biotech Limited | 3.08 Billion INR | 40.641% |
Dishman Carbogen Amcis Limited | -1.53 Billion INR | 219.184% |
Lyka Labs Limited | -24.89 Million INR | 7446.67% |
Panacea Biotec Limited | -11.73 Million INR | 15691.475% |
Piramal Pharma Limited | 178.2 Million INR | -926.308% |
SMS Lifesciences India Limited | 90.92 Million INR | -1911.35% |
Supriya Lifescience Limited | 1.19 Billion INR | -53.54% |
Syngene International Limited | 5.1 Billion INR | 64.14% |
TAKE Solutions Limited | -1.19 Billion INR | 252.891% |
Zota Health Care Limited | -143.47 Million INR | 1374.667% |